key: cord-0968710-jtu59u99
authors: Geerdink, Ruben J.; Pillay, Janesh; Meyaard, Linde; Bont, Louis
title: Neutrophils in respiratory syncytial virus infection: A target for asthma prevention
date: 2015-08-12
journal: J Allergy Clin Immunol
DOI: 10.1016/j.jaci.2015.06.034
sha: b1735d2bf2120775db46e1803d1c92023d22e60d
doc_id: 968710
cord_uid: jtu59u99

Lower respiratory tract infections by respiratory syncytial virus (RSV) are the foremost cause of infant hospitalization and are implicated in lasting pulmonary impairment and the development of asthma. Neutrophils infiltrate the airways of pediatric patients with RSV-induced bronchiolitis in vast numbers: approximately 80% of infiltrated cells are neutrophils. However, why neutrophils are recruited to the site of viral respiratory tract infection is not clear. In this review we discuss the beneficial and pathologic contributions of neutrophils to the immune response against RSV infection. Neutrophils can limit viral replication and spread, as well as stimulate an effective antiviral adaptive immune response. However, low specificity of neutrophil antimicrobial armaments allows for collateral tissue damage. Neutrophil-induced injury to the airways during the delicate period of infant lung development has lasting adverse consequences for pulmonary architecture and might promote the onset of asthma in susceptible subjects. We suggest that pharmacologic modulation of neutrophils should be explored as a viable future therapy for severe RSV-induced bronchiolitis and thereby prevent the inception of subsequent asthma. The antiviral functions of neutrophils suggest that targeting of neutrophils in patients with RSV-induced bronchiolitis is best performed under the umbrella of antiviral treatment.

Respiratory syncytial virus (RSV) is a ubiquitous seasonal human pathogen that, on infection of the upper respiratory tract, causes cold-like symptoms in most healthy adults and children. At 2 years of age, nearly all children will have been infected with RSV at least once. Lower respiratory tract infections (LRTIs) by RSVare a major cause of morbidity and mortality among infants. Annual RSV-associated mortality is estimated at a quarter million deaths per year, of which 99% occur in developing countries, and it accounts for approximately 7% of deaths among infants younger than 1 year of age. 1 In the developed world 1% to 2% of infants are admitted to the hospital with RSV-induced bronchiolitis; therefore it is the foremost cause of infant hospitalization during the winter season. 2, 3 Severe RSV-induced bronchiolitis in infancy is linked to impaired lung function in adulthood and causally implicated in the onset of recurrent wheezing and asthma. [4] [5] [6] [7] Massive pulmonary neutrophil infiltration is observed in pediatric patients with RSV-induced bronchiolitis. [8] [9] [10] In the lower airways neutrophils account for a median of 76% of infiltrated cells and a median of 93% in the upper airways, as measured in bronchoalveolar lavage fluid and nasopharyngeal aspirates, respectively. 9 Similarly, postmortem histopathologic analyses of fatal RSV-related LRTI cases reveal extensive neutrophil infiltration of the airway wall and lumen, as well as the alveoli. 11 This begs the question of why neutrophils are recruited en masse to the site of viral respiratory tract infection. A wide variety of inflammatory stimuli purposefully attract neutrophils to the lungs, such as to clear invading bacteria, apoptotic debris, or foreign substances. Could neutrophils also function protectively during RSV infection?

Neutrophils, the most abundant leukocytes in human circulation, are classically portrayed as unsophisticated, first-line foot soldiers with a role limited to the engulfment and subsequent elimination of invading extracellular bacteria and fungi. In this view lung-infiltrated neutrophils seem out of place during RSV infection. The promiscuous cytotoxicity of neutrophil antimicrobial armaments might even potentiate virus-induced lung injury. 12 Indeed, the degree of neutrophilic inflammation correlates with disease severity in patients with RSV-induced bronchiolitis. 13 Moreover, a common single nucleotide polymorphism just upstream of the IL-8encoding gene that is tentatively associated with increased production of IL-8, a potent neutrophil chemoattractant, is more frequent among infants with severe RSV-induced bronchiolitis, in particular among infants who lack other known risk factors. 14 Increased IL-8 levels in the airways of patients with bronchiolitis are linked to increased disease severity, as measured based on oxygen saturation, Silverman score, and respiratory rate. 15, 16 Genes related to neutrophil function, such as those encoding a-defensin-1 and elastase, are overexpressed in the blood of patients with RSV-induced bronchiolitis, and expression levels positively correlate with disease severity. 17 Thus neutrophils are thought to contribute to lung injury in patients with severe RSV-induced bronchiolitis, but their exact role in pathogenesis is still unclear.

A large body of epidemiologic evidence, including prospective case-control and cohort studies, implicates RSV-induced bronchiolitis during infancy in the inception of recurrent wheeze and lasting lung function impairment. [5] [6] [7] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] However, the association between wheeze and a history of RSV-induced bronchiolitis during infancy partially subsides with age. 7,32 It is not clear to what extent RSV-induced bronchiolitis is related to increased risk of asthma at school age or beyond. Nonetheless, nearly half of children with severe RSV-induced bronchiolitis present with asthma at 6 years of age. 5 Estimates indicate that early-life RSV-induced bronchiolitis is responsible for up to 13% of childhood asthma cases. 24 Moreover, smoking adults with RSVinduced bronchiolitis during infancy, but not those without LRTIs in early life, have an increased risk of persistent asthma. 26 However, association does not necessarily imply causation. Severe RSV-induced bronchiolitis could occur mainly in infants with pre-existing susceptibility to asthma development. Common genetic and/or environmental factors appear to underlie predisposition to both diseases. 21 We recently addressed the issue of causality in a randomized, double-blind, placebo-controlled clinical trial with RSV immunoprophylaxis of healthy preterm infants, in which we demonstrated a causal relationship between RSV-induced bronchiolitis and the development of recurrent wheeze. 4 Although wheezing in early life is a strong risk factor for asthma in (early) adulthood, 33 asthma trials are needed to provide conclusive evidence that RSV disease is causally related to persistent asthma.

Neutrophils play an important role in asthma exacerbations by inducing mucus hypersecretion and airway remodeling, which result in acute reversible and progressive irreversible airway obstruction, respectively. 34, 35 Although neutrophils are thought to affect lung function decrease, their role in asthma inception during viral bronchiolitis is understudied. Nonetheless, the severity of infant bronchiolitis shows a dose-response relationship with the risk and morbidity of childhood asthma, 22 and as discussed above, the degree of neutrophilic inflammation correlates with the severity of RSV-induced bronchiolitis. 13, 15, 16 Therefore severe neutrophilic lung inflammation during infancy could tenably predispose children to subsequent wheezing and onset of asthma. Indeed, a functional IL-8 polymorphism more frequent among infants with severe RSV-induced bronchiolitis is also overrepresented in infants who had postbronchiolitis wheezing compared with patients with bronchiolitis who did not have wheezing afterward. 14,36 Neutrophilic inflammation-induced collateral tissue damage and airway sensitization could mediate the development of asthma susceptibility.

Transient damage to development of infant lungs can have farreaching and lasting adverse consequences for pulmonary anatomy and function; this is particularly true if the critical process of alveolar multiplication by septation is disrupted. 37 Elastin fibers, which are present in alveolar duct and septal walls, provide elasticity to the lungs and transmit cues of mechanical stress to stimulate alveolarization. Neutrophil elastase, which is released on neutrophil recruitment to the lungs, degrades elastin fibers and thereby demolishes lung tissue structure. 38 Through elastase release and other lung-damaging mechanisms discussed below, the massive pulmonary neutrophil infiltrate of pediatric patients with RSV-induced bronchiolitis might thus cause irreparable disruption of lung development that predisposes these infants to subsequent asthma inception (Fig 1) . In addition to inducing airway remodeling through collateral tissue damage, neutrophils might sensitize the airways to asthma through mast cell recruitment. IL-9 is detected in the bronchoalveolar lavage fluid of patients with RSV-induced bronchiolitis, and airwayinfiltrated neutrophils are the principal producers. 39 In response to pulmonary expression of IL-9, long-lived mast cells migrate to and accumulate in lung tissue. 40, 41 Lung-resident mast cells, specifically those located in the bronchial smooth muscle bundles, contribute to airway hyperresponsiveness and are considered crucial to the pathogenesis of (allergic) asthma (Fig 1) . 42 Dampening excessive neutrophilic inflammation during RSVinduced bronchiolitis might protect lung function, curtail airway sensitization, and reduce the risk of recurrent wheezing and asthma. A proof-of-concept, randomized, double-blind, placebocontrolled trial of macrolide treatment in patients with RSVinduced bronchiolitis provides tentative clinical support in favor of dampening neutrophilic inflammation. 43 Macrolides have antineutrophilic activities in vitro and attenuate neutrophilic airway inflammation in patients with refractory asthma and during RSV infection in mice. [44] [45] [46] In comparison with placebo-treated patients, macrolide-treated patients with RSV-induced bronchiolitis showed reduced nasal lavage IL-8 levels, experienced fewer days after bronchiolitis with respiratory symptoms, tended toward fewer subsequent wheezing episodes, and exhibited a delayed third wheezing episode. 43 RSV immunoprophylaxis is costly and available only to highrisk infants, for whom it reduces RSV-related hospitalization by approximately 50%. 47 For patients, supportive care is the sole treatment regimen available. Clearly, new treatment options for severe RSV-induced bronchiolitis are required to ameliorate disease and reduce sequelae, asthma in particular. The prominent neutrophilic inflammation in patients with RSV-induced bronchiolitis represents a promising target.

Below, we examine the role of neutrophils in patients with RSV infection and discuss the relevance thereof for therapy and asthma prevention. Because studies performed with RSV in this regard are scarce, we will also draw information from the literature on other viruses, in particular influenza virus, infections with which also exhibit severe pulmonary neutrophil infiltration.

Neutrophils can injure the lungs in multiple ways: (1) release of proteolytic enzymes, including elastase, into the microenvironment through degranulation; (2) production of reactive oxygen species (ROS); (3) formation of neutrophil extracellular traps (NETs) by the cell death program known as NETosis; and (4) stimulation of mucus production (Fig 2) .

Neutrophil migration into the airways during influenza infection in mice depends on the neutrophil tertiary granule-expressed matrix metalloproteinase (MMP) 9, which digests extracellular Protective and lung-injurious roles of neutrophils during respiratory tract viral infection. Neutrophilinduced mucus production limits access of viral particles to the epithelium but obstructs airflow. Degranulation releases antimicrobial mediators that are also cytotoxic to host cells. Phagocytosis of (opsonized) viral particles and virus-infected cells limits viral spread. NETs capture and deactivate viral particles but also damage healthy bystander cells. ECM, Extracellular matrix; PRMs, pattern recognition molecules.

matrix. MMP9-mediated neutrophil influx into the airways is required for the control of influenza virus replication in mouse lungs. 48 However, excessive MMP9 proteolytic activity in response to high viral loads exacerbates pathology. 48 Pulmonary inflammation caused by noninfectious agents, such as cigarette smoke, implicate other neutrophil proteolytic enzymes, including cathepsin G, neutrophil elastase, and proteinase 3, in lung tissue destruction as well. 49 The inflammatory milieu in the lungs during RSV infection induces the neutrophil oxidative burst. 50 The abundantly produced ROS indiscriminately oxidize biomolecules, which compromises their function. Therefore ROS are potently antimicrobial but also damage host cellular structures. Oxidative stress during RSV infection promotes lung injury. 51, 52 Thus neutrophil-derived ROS are likely to contribute to lung damage in patients with RSV infection.

NETs are DNA-based meshes decorated with histones and granular antimicrobial proteins and peptides, including elastase, myeloperoxidase (MPO), and a-defensins. By trapping microbes in NETs, microbial spread can be minimized and microbe killing optimized by high local concentrations of antimicrobial proteins and peptides. 53 Exposure of neutrophils to RSV particles in vitro induces NET formation through specific interaction of RSV fusion (F) protein with neutrophil-expressed Toll-like receptor (TLR) 4. 54 Data on the in vivo antiviral activity of NETs are conflicting. 55 Genetic ablation of peptidylarginine deiminase 4, which is required for NET formation, did not affect viral replication or mortality in mice infected with influenza virus. 56 Instead, NETs are located in areas of alveolar damage in the lungs of influenza virus-infected mice. 57 In vitro NETs directly damage alveolar epithelial and endothelial cells. The histone component of NETs is chiefly responsible for this cytotoxic effect. 58 This suggests that NETs induce lung injury rather than suppressing viral replication. However, the absence of NETs in peptidylarginine deiminase 4-deficient mice does not reduce lung pathology during influenza infection either. 56 In this mouse model of human influenza virus infection, NETs appear to play neither a beneficial nor a pathologic role. The contribution of NETs during viral infection might be virus specific and depend on the degree of NET induction.

In addition to directly damaging the respiratory tract, neutrophils can contribute to airway obstruction by inducing mucus production. Mucus forms a protective barrier to viral infection by limiting access of viral particles to the pulmonary epithelium. However, excessive mucus production might cause airway obstruction. Mouse neutrophils promote the expression of mucin, the chief component of mucus, during RSV infection. 59 Thus the extensive neutrophil infiltration in the lungs might contribute to the airway obstruction and resultant wheezing observed in patients with severe RSV-induced bronchiolitis.

Pulmonary IL-17 enhances neutrophil recruitment to the lungs early in RSV infection by inducing IL-8 production in airway epithelial cells. 60 The amount of IL-17 in the lungs of pediatric patients with RSV-induced bronchiolitis correlates to the degree of subsequent pulmonary neutrophil influx. 60 Additionally, IL-17 induces the production of obstructive mucus in the airways. 61 This suggests that IL-17 plays a pathogenic role during LRTIs by RSV. The association of a polymorphism in the gene encoding IL-17 with severe RSV-induced bronchiolitis supports this notion. 62 Moreover, the response of T H 17 cells, noted producers of IL-17, is enhanced in infants with RSV-induced bronchiolitis. 63 An RSV mouse model also links IL-17 and T H 17 responses to RSV disease severity: pulmonary neutrophil recruitment and lung pathology are exacerbated in RSV-infected mice, which have increased T H 17 responses caused by genetic ablation of the IL-27 receptor. 64 Moreover, genetic ablation or antibody-mediated blocking of IL-17 in RSV-infected mice reduces neutrophilic inflammation, mucus production, and viral loads and improves the cytotoxic T-cell response against RSV. 65 Nonetheless, it is not clear whether local IL-17 levels are protective or harmful. IL-17 reduces airway reactivity of RSV-infected mice presensitized with ovalbumin, 66 and mice that received a novel attenuated Bordetella pertussis vaccine were protected from RSV infection in an IL-17-dependent fashion. 67 It is possible that a limited IL-17 response is protective, whereas excessive IL-17 production induces immune pathology through unrestrained neutrophil recruitment. However, the early recruitment of neutrophils to the lungs of patients with RSV-induced bronchiolitis is unlikely to be mediated by an adaptive T H 17 response because RSV antigen-driven clonal expansion and differentiation of T H 17 cells require several days. Instead, there might be a role for natural T H 17 cells that acquire effector functions during thymic development and regulate early-phase airway neutrophil responses. 68, 69 Thus (natural) T H 17 cells and IL-17 might promote a pathogenic neutrophildominated response to RSV infection.

The neutrophil antimicrobial arsenal, although damaging to the lungs if deployed excessively, has also shown efficacy against viruses in addition to its traditional bacterial and fungal targets. Based on this, a contribution of neutrophils to antiviral defense is suggested. 55, 70, 71 Indeed, a beneficial role for neutrophils in patients with viral respiratory tract infections has been reported for influenza virus. [72] [73] [74] [75] Neutrophil depletion in mice by neutrophil-specific anti-Ly6G antibody treatment results in enhanced viral replication and lung damage. 72 Therefore neutrophil recruitment to the airways during RSV infection could also be a protective response. Neutrophils mediate direct antimicrobial effects through, in essence, 3 known effector mechanisms, namely (1) phagocytosis, (2) degranulation, and (3) NET formation (Fig 2 and Table I ). [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] By means of phagocytosis, neutrophils can eliminate RSVinfected cells, thereby preventing further viral replication, and engulf virions to limit infection of new cells. Blocking the recognition and phagocytosis of apoptotic cells by local Annexin V administration 1 day after influenza virus inoculation increases mortality among mice. 76 Both mouse macrophages and neutrophils phagocytose influenza virus-infected apoptotic cells in vivo. 77 This process is amplified by TLR4, 77 which recognizes RSV F protein expressed on the surfaces of virions and infected cells. 87 Moreover, as shown in vitro for herpes simplex virus, antibody-and complement-mediated opsonization facilitates the phagocytosis of viral particles and virus-infected cells by neutrophils. 88 Neutrophil granules contain antimicrobial proteins and peptides, including a-defensins 1 to 4 (or human neutrophil peptides [HNPs] 1-4), cathelicidins (ie, LL-37), pentraxin (PTX) 3, and MPO, which are released into the microenvironment on degranulation. 89 Neutrophils degranulate in response to in vitro stimulation with RSV particles. 90 HNPs are small, cationic amphipathic peptides that demonstrate antiviral activity. For instance, multiple steps of cellular entry by HIV-1 are inhibited by HNP-1, 78 and HNPs promote influenza virus aggregation and uptake by neutrophils. 79 Whether the antiviral activity of HNPs extends to RSV is not currently known, but the broad antiviral activities of HPNs against multiple enveloped and nonenveloped viruses hints at the possibility. 91 Recent in vitro work demonstrates that the cationic antimicrobial peptide LL-37 possesses direct antiviral activity against RSV virions, protects infected epithelial cells against RSV-induced cell death, inhibits production of new viral particles, and reduces the susceptibly of epithelial cells to RSV infection. 80 Low serum levels of LL-37 precursor (ie, hCAP-18) are associated with severe infantile RSV-induced bronchiolitis. 81 PTXs are soluble pattern recognition molecules that recognize pathogen-associated molecular patterns and mediate innate humoral immunity, functionally resembling antibodies of the adaptive immune system. PTX3 can activate compliment through recruitment of C1q (ie, the classical pathway) and act as opsonins by interacting with the FcgRIII (CD16) and FcgRII (CD32) receptors, which are expressed by phagocytes, including neutrophils. 92 Mature neutrophils represent a major reservoir of preformed ready-to-use PTX3, as well as other pattern recognition molecules. 93 Direct evidence of PTX3-mediated antiviral activity against RSV is lacking but has been demonstrated for influenza virus and mouse coronavirus. PTX3 reduces the infectivity of both viruses. Moreover, PTX3-deficient mice inoculated with either virus fare worse than their wild-type counterparts but can be rescued by administration of exogenous PTX3. 82, 83 MPO catalyzes the production of hypochlorous acid, which is a potent antimicrobial ROS, because of its ability to chlorinate and oxidize a great variety of biomolecules. Secreted and NET-bound MPO deactivates HIV-1 particles in vitro. 84, 85 The RSV F protein induces formation of MPO-coated NETs through TLR4, 54 and HIV-1 triggers NETosis through a TLR7/TLR8-and ROSdependent pathway. NET-bound MPO and HNPs abolish the infectivity of HIV-1 particles. In coculture neutrophils reduce the infection of CD4 1 T cells by HIV-1 in a NET-dependent manner. 85 Thus NETs are elicited by stimulation with virus and possess direct antiviral activity in vitro.

Furthermore, the release of NETs by neutrophils during intravenous myxoma poxvirus challenge in mice protects against viral infection of liver cells. 86 Therefore NETs can benefit antiviral defense in vivo. As discussed above, NETosis deficiency does not affect the course of disease in human influenza virus-inoculated mice. 56 A contribution, protective or damaging, of NETs to antiviral defense might be virus and organ (eg, liver vs lung) specific.

Recent studies demonstrate multiple immune regulatory functions for neutrophils. In addition to their role as effector cells in patients with RSV infection described above, neutrophils can also act as immune regulatory cells (Fig 3) . Although neutrophilmediated immune regulation in the context of RSV infection has yet to be examined directly, general concepts can be derived from studies with other viruses and guide further research into the severely understudied role of neutrophils in patients with RSV infection. Here we focus on regulatory roles potentially involved in RSV infection. For a more complete overview, the reader is referred to a number of recent reviews. 89, [93] [94] [95] Neutrophils can promote antiviral CD8 1 T-cell responses. Influenza virus antigen-displaying neutrophils stimulate lunginfiltrated CD8 1 T cells to produce IFN-g, whereas infected epithelial cells only elicit their own cytolysis. 96, 97 Stimulation of IFN-g production by neutrophils can enhance antiviral defense against RSV infection. 98 The CD8 1 T-cell response to influenza in the airways of mice is maintained by infiltrated neutrophils. 75 Neutrophils thus regulate CD8 1 T-cell effector function at the site of viral infection. Neutrophils efficiently cross-present phagocytosed antigen to naive CD8 1 T cells in vivo to stimulate proliferation, IFN-g production, and cytolytic activity. 99 By acting as viral antigen shuttles, neutrophils can indirectly induce an antiviral CD8 1 T-cell response. Mouse neutrophils take up modified vaccinia Ankara virus in skin, transport viral antigen to the bone marrow, and there, through local phagocytic antigen-presenting cells, trigger virus-specific CD8 1 T-cell proliferation and establishment of memory. 100 Moreover, neutrophils can indirectly stimulate T-cell responses by recruiting immature dendritic cells (DCs) to a site of infection through CCL3 secretion 101 and by inducing DC maturation through direct cell-cell contact, which depends on altered glycosylation patterns of Mac-1 (CD11b/CD18) and carcinoembryonic antigen-related cell adhesion molecule 1 (CAECAM1) that are specific to activated neutrophils. 102, 103 The homeostasis of innate cytotoxic lymphocytes (ie, natural killer [NK] cells) is neutrophil dependent. [104] [105] [106] Neutropenic patients and neutrophil-depleted mice present with immature hyporesponsive NK cells. 104 Neutrophils stimulate NK cells through IL-18 production and the interaction of The adaptive humoral response is stimulated by neutrophils as well. Through cytokine secretion (ie, B cell-activating factor of the TNF family [BAFF], a proliferation inducing ligand [APRIL], and IL-21), splenic neutrophils induce immunoglobulin classswitch recombination, somatic hypermutation, and antibody production by marginal zone B cells. 107 Neutrophils can also suppress adaptive immune responses. Systemic inflammation in human subjects induces a neutrophil subset with T cell-suppressive capabilities. These suppressive neutrophils form Mac-1-dependent immunologic synapses with T cells and locally produce bursts of membrane-associated hydrogen peroxide (H 2 O 2 ) that suppress T-cell proliferation. 108 Furthermore, neutrophil-derived thromboxane limits T-cell cytokine production in response to protein-in-adjuvant vaccination of mice and suppresses the spread of the T-cell response from the draining lymph nodes of the injection site to distal lymph nodes. 109 Neutrophils can indirectly suppress T-cell responses through deposition of MPO in lymph nodes, which impairs DC function. 110 In a more passive manner neutrophils might contribute to the resolution of inflammation. Depending on environmental stimuli, macrophages can acquire a proinflammatory or proresolution phenotype. The phagocytosis of apoptotic neutrophils by macrophages induces a regulatory phenotype in macrophages, which might contribute to the resolution of inflammation. 111 In RSVinfected cotton rats, proresolution macrophages limit lung pathology. 112 

Is it conceivable that neutrophils are abundantly present in the airways during severe RSV infection without playing a major role in either the pathogenesis of bronchiolitis or the subsequent inception of asthma? Although indicators of neutrophilic inflammation, including airway IL-8 levels and neutrophil elastase activity, correlate with the severity of bronchiolitis, cell counts of airway-infiltrated neutrophils, which are invariably high, are not associated with RSV disease severity. 10, 13, 15, 16, 113 Similar to RSV-induced bronchiolitis, extensive neutrophil infiltration of the airways and alveoli is observed during bacterial pneumonia, usually in the absence of wheezing. If neutrophils contribute to the inception of asthma after bronchiolitis, an increased risk of asthma should also be observed after bacterial respiratory tract infections in early childhood. Evidence in support of this is limited to observations in a high-risk birth cohort. 31 Future studies should attempt to validate the relationship between bacterial respiratory tract infection during infancy and the subsequent development of reactive airway disease.

The vast number of lung-infiltrating neutrophils in patients with RSV-induced bronchiolitis appears to be the principal instigator of pulmonary immunopathology. The secretion of proteolytic enzymes, such as elastase, the production of ROS, and NET release can clearly injure the lungs. This might disrupt the delicate process of lung development in infancy and have lasting adverse consequences for lung anatomy, function, and susceptibility to chronic disease, including asthma. However, through direct antiviral activity of these and other neutrophil mechanisms, as well as through regulation of adaptive immune responses, neutrophils can also contribute to a protective antiviral response. In patients with severe RSV-induced bronchiolitis, the balance between neutrophil antimicrobial activity and collateral tissue damage appears to have shifted toward a pathologic response. Hence pharmacologic suppression of neutrophil activity could curtail lung injury. Possible approaches include (1) neutrophil-inhibitory macrolides 43,46 ; (2) inhibiting damaging neutrophil-derived products, such as elastase 114 ; (3) antagonizing neutrophil-modulatory adenosine 115 ; (4) neutrophil chemokine receptor blockade 116, 117 ; (5) and targeting neutrophil-expressed inhibitory receptors. 118, 119 We eagerly await the results of future clinical trials for the treatment of RSV infection with pharmacologic agents that can effectively dampen neutrophilic inflammation, such as the selective small-molecule CXCR2 (IL-8 receptor) antagonist danirixin (ClinicalTrials.gov identifier: NCT02201303). 117 The relationship between extensive neutrophil infiltration of the airways in early life and later asthma development might not be limited to RSV infection. Lower respiratory tract illnesses in infants induced by other viruses are also associated with subsequent wheeze and asthma. 7,31,120 Limited evidence also hints at a causal association between bacterial invasion of the respiratory tract and subsequent asthma development. [121] [122] [123] Colonization of neonatal airways by pathogenic bacteria induces neutrophil response-associated cytokines and is associated with development of persistent wheezing and childhood asthma in a prospective birth cohort. 124, 125 Moreover, among prospectively followed high-risk children, respiratory tract infections by pathogenic bacteria in early life were associated with an increased risk of school-age asthma. 31 In fact, rather than a specific viral or bacterial pathogen, the total number of early respiratory tract infections correlated with the risk of childhood asthma in this study. 31 Although injurious when present in excess, neutrophils are essential to antimicrobial defense. The safety of treating RSVinduced bronchiolitis with neutrophil suppression could improve with the administration of RSV antivirals and prophylactic antibiotics. Recently, a newly developed RSV antiviral was successfully tested in a clinical trial wherein healthy adult subjects were challenged with RSV. 126 By itself, however, an RSV antiviral might confer limited benefit when administered several days after onset of symptoms. For influenza, oseltamivir is only effective when administered within 36 to 48 hours after symptom onset. 127 Similarly, antiviral treatments against RSV should ideally be administered as close to initial infection as possible to be at their most effective, yet RSV loads are already on the decrease when patients are admitted to the intensive care unit. 128 Nonetheless, neutrophils are still abundantly present in the lungs, [9] [10] [11] and thus neutrophil-mediated damage to the airways persists (Fig 2) . Therefore we propose that suppressing neutrophil activity under the umbrella of RSVantivirals and prophylactic antibiotics offers a promising treatment strategy to improve the outcomes of infants with RSV-induced bronchiolitis and reduce the risk of subsequent asthma.

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study

Herv as JA. Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis

Dutch RSV Neonatal Network. Respiratory syncytial virus and recurrent wheeze

Determinants of asthma after severe respiratory syncytial virus bronchiolitis

Adults face increased asthma risk after infant RSV bronchiolitis and reduced respiratory health-related quality of life after RSV pneumonia

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

The respiratory syncytial virus and its role in acute bronchiolitis

Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection

Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis

Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses

The balancing act of neutrophils

Neutrophil-mediated inflammation in respiratory syncytial viral bronchiolitis

Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families

Neutrophil but not eosinophil inflammation is related to the severity of a first acute epidemic bronchiolitis in young infants

Respiratory syncytial virus bronchiolitis: Disease severity, interleukin-8, and virus genotype

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection

Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7

Effects of viral respiratory infections on lung development and childhood asthma

The causal direction in the association between respiratory syncytial virus hospitalization and asthma

The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma

Are severe lung infections in the first 2 years of life related to lung function at 18 years

Risk of childhood asthma following infant bronchiolitis during the respiratory syncytial virus season

Increased risk of wheeze and decreased lung function after respiratory syncytial virus infection

Risk of current asthma among adult smokers with respiratory syncytial virus illnesses in early life

Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma

Evidence for a causal relationship between respiratory syncytial virus infection and asthma

Bj€ orkst en B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls

Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study

Association between respiratory infections in early life and later asthma is independent of virus type

Association between respiratory syncytial virus hospitalizations in infants and respiratory sequelae: systematic review and meta-analysis. Pediatr

Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study

Is the neutrophil a worthy target in severe asthma and chronic obstructive pulmonary disease?

Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?

Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis

Transient induction of TGF-alpha disrupts lung morphogenesis, causing pulmonary disease in adulthood

Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitordeficient mice

Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis

IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways

TH9 cells are required for tissue mast cell accumulation during allergic inflammation

The role of the mast cell in the pathophysiology of asthma

Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis

Chronic macrolide therapy in inflammatory airways diseases

Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis

Clarithromycin targets neutrophilic airway inflammation in refractory asthma

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants

Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling

Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema

Respiratory syncytial virus and neutrophil activation

Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes

Viralmediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis

Neutrophil extracellular traps kill bacteria

Respiratory syncytial virus fusion protein promotes TLR-4-dependent neutrophil extracellular trap formation by human neutrophils

Virus-induced NETs-critical component of host defense or pathogenic mediator?

PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection

Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis

Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones

The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection

Local IL-17A potentiates early neutrophil recruitment to the respiratory tract during severe RSV infection

IL-17A induces signal transducers and activators of transcription-6-independent airway mucous cell metaplasia

Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes

Elevated Th17 response in infants undergoing respiratory viral infection

IL-27R-mediated regulation of IL-17 controls the development of respiratory syncytial virus-associated pathogenesis

IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease

IL-17A inhibits airway reactivity induced by respiratory syncytial virus infection during allergic airway inflammation

Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism

Natural occurring IL-17 producing T cells regulate the initial phase of neutrophil mediated airway responses

Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways

Neutrophils: neglected players in viral diseases

Neutrophil in viral infections, friend or foe?

Neutrophils ameliorate lung injury and the development of severe disease during influenza infection

Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung

The role of neutrophils during mild and severe influenza virus infections of mice

Neutrophils sustain effective CD8(1) T-cell responses in the respiratory tract following influenza infection

Augmentation of fatality of influenza in mice by inhibition of phagocytosis

Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice

Multifaceted mechanisms of HIV-1 entry inhibition by human a-defensin

Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses

The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus

Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis

Antiviral activity of the long chain pentraxin PTX3 against influenza viruses

Protective effects of long pentraxin PTX3 on lung injury in a severe acute respiratory syndrome model in mice

Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system

Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1

Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

Phagocytosis of herpes simplex virus by human granulocytes and monocytes

Neutrophil function: from mechanisms to disease

Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release

Antiviral mechanisms of human defensins

An integrated view of humoral innate immunity: pentraxins as a paradigm

Neutrophils in the activation and regulation of innate and adaptive immunity

Diverse novel functions of neutrophils in immunity, inflammation, and beyond

Social networking of human neutrophils within the immune system

Antiviral CD81 T cell effector activities in situ are regulated by target cell type

Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(1) T cells

Effect of lack of Interleukin-4, Interleukin-12, Interleukin-18, or the Interferon-gamma receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice

Neutrophils efficiently cross-prime naive T cells in vivo

Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD81 T cells

Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of Leishmania major inoculation in resistant mice

Neutrophils mediate immune modulation of dendritic cells through glycosylationdependent interactions between Mac-1 and DC-SIGN

Interactions of DC-SIGN with Mac-1 and CEACAM1 regulate contact between dendritic cells and neutrophils

Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis

Human neutrophils interact with both 6-sulfo LacNAc1 DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3

A novel role for neutrophils as critical activators of NK cells

B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1

Neutrophils control the magnitude and spread of the immune response in a thromboxane A2-mediated process

Neutrophil myeloperoxidase regulates T-cell-driven tissue inflammation in mice by inhibiting dendritic cell function

Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10(high) regulatory phenotype in macrophages

Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease

The potential of neutrophil elastase inhibitors as anti-inflammatory therapies

Regulation of neutrophil function by adenosine

Interleukin-8 receptor antagonists in pulmonary diseases

The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers

Signal inhibitory receptor on leukocytes-1 (SIRL-1) negatively regulates the oxidative burst in human phagocytes

Ligation of signal inhibitory receptor on leukocytes-1 suppresses the release of neutrophil extracellular traps in systemic lupus erythematosus

Rhinovirus wheezing illness and genetic risk of childhood-onset asthma

The relationships between environmental bacterial exposure, airway bacterial colonization, and asthma

Infections and their role in childhood asthma inception

Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations

Childhood asthma after bacterial colonization of the airway in neonates

Pathogenic bacteria colonizing the airways in asymptomatic neonates stimulates topical inflammatory mediator release

Oral GS-5806 activity in a respiratory syncytial virus challenge study

Neuraminidase inhibitors: who, when, where?

A systemic neutrophil response precedes robust CD8(1) T-cell activation during natural respiratory syncytial virus infection in infants